Zobrazeno 1 - 10
of 998
pro vyhledávání: '"Feeley TW"'
Autor:
Nagra NS; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. navraj.nagra@doctors.org.uk.; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA. navraj.nagra@doctors.org.uk., Tsangaris E; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Means J; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA, USA., Dominici LS; Dana-Farber Cancer Institute, Boston, MA, USA., Bellon JR; Dana-Farber Cancer Institute, Boston, MA, USA., Broyles J; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Kaplan RS; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA., Feeley TW; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA., Pusic AL; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2022 Jan; Vol. 29 (1), pp. 510-521. Date of Electronic Publication: 2021 Aug 10.
Autor:
Thaker NG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Radiation Oncology, Arizona Oncology, The US Oncology Network, Tucson, AZ., Kudchadker RJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Incalcaterra JR; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX., Bathala TK; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kaplan RS; Harvard Business School, Boston, MA., Agarwal A; Department of Radiation Oncology, The University of North Carolina, Chapel Hill, NC., Kuban DA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Frank BD; Provision Healthcare, Nashville, TN., Das P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Feeley TW; Harvard Business School, Boston, MA., Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: sjfrank@mdanderson.org.
Publikováno v:
Brachytherapy [Brachytherapy] 2022 Jan-Feb; Vol. 21 (1), pp. 49-54. Date of Electronic Publication: 2021 Aug 10.
Autor:
Nagra NS; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. navraj.nagra@doctors.org.uk.; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA. navraj.nagra@doctors.org.uk., Tsangaris E; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Means J; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA, USA., Dominici LS; Dana-Farber Cancer Institute, Boston, MA, USA., Bellon JR; Dana-Farber Cancer Institute, Boston, MA, USA., Broyles J; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Kaplan RS; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA., Feeley TW; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA., Pusic AL; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2021 Dec; Vol. 28 (Suppl 3), pp. 899.
Autor:
McClintock TR; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Division of Urology, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA; Harvard Business School, Boston, MA. Electronic address: tmcclintock@partners.org., Friedlander DF; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC., Feng AY; Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Shah MA; Harvard Business School, Boston, MA., Pallin DJ; Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Chang SL; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Bader AM; Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Feeley TW; Harvard Business School, Boston, MA; The Institute for Cancer Care Innovation and Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX., Kaplan RS; Harvard Business School, Boston, MA., Haleblian GE; Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publikováno v:
Urology [Urology] 2021 Nov; Vol. 157, pp. 107-113. Date of Electronic Publication: 2021 Aug 12.
Autor:
Karhade AV; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA; Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: akarhade@mba2020.hbs.edu., Bono CM; Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Makhni MC; Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Schwab JH; Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Sethi RK; Neuroscience Institute, Virginia Mason Medical Center, Seattle, WA, USA; Department of Neurosurgery, Virginia Mason Medical Center, Seattle, WA, USA., Simpson AK; Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Feeley TW; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA., Porter ME; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA.
Publikováno v:
The spine journal : official journal of the North American Spine Society [Spine J] 2021 Sep; Vol. 21 (9), pp. 1409-1413. Date of Electronic Publication: 2021 Apr 20.
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer.
Autor:
Thaker NG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arizona Oncology, The US Oncology Network, Tucson, AZ, USA., Boyce-Fappiano D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ning MS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guzman A; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Smith G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Holliday EB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Incalcaterra J; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shaitelman SF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Blanchard P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Feeley TW; Harvard Business School, Boston, MA, USA., Kaplan RS; Harvard Business School, Boston, MA, USA., Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
International journal of particle therapy [Int J Part Ther] 2021 Jun 25; Vol. 8 (1), pp. 374-382. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
Autor:
Allen CJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas., Eska JS; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thaker NG; Department of Radiation Oncology, Arizona Oncology, Tucson, Arizona., Feeley TW; Institute for Strategy and Competitiveness, Harvard Business School, Boston, Massachusetts., Kaplan RS; Institute for Strategy and Competitiveness, Harvard Business School, Boston, Massachusetts., Huey RW; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tzeng CD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Frank SJ; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Aloia TA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gottumukkala V; The Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Anesthesia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: mhgkatz@mdanderson.org.
Publikováno v:
The Journal of surgical research [J Surg Res] 2021 Jun; Vol. 262, pp. 115-120. Date of Electronic Publication: 2021 Feb 06.
Autor:
Reitblat C; Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Harvard Business School, Boston, MA, USA., Bain PA; Countway Library, Harvard Medical School, Boston, MA, USA., Porter ME; Harvard Business School, Boston, MA, USA; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA., Bernstein DN; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA; Harvard Combined Orthopedic Residency Program (HCORP), Massachusetts General Hospital, Boston, MA, USA., Feeley TW; Harvard Business School, Boston, MA, USA; Institute for Strategy and Competitiveness, Harvard Business School, Boston, MA, USA., Graefen M; Martini-Klinik, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Iyer S; Harvard Business School, Boston, MA, USA., Resnick MJ; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA; Embold Health, Nashville, TN, USA., Stimson CJ; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA., Trinh QD; Harvard Medical School, Boston, MA, USA; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA., Gershman B; Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: bgershma@bidmc.harvard.edu.
Publikováno v:
European urology [Eur Urol] 2021 May; Vol. 79 (5), pp. 571-585. Date of Electronic Publication: 2021 Jan 04.
Autor:
Kukreja JB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX; Division of Urology, Department of Surgery, University of Colorado, Boulder, CO., Seif MA; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX., Mery MW; Department of Critical Care, Baylor College of Medicine, Houston, TX., Incalcaterra JR; Value Measurement and Analysis, University of Texas MD Anderson Cancer Center, Houston, TX., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX., Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX., Shah JB; Department of Urology, Stanford University School of Medicine, Stanford, CA., Feeley TW; Harvard Business School, Boston, MA., Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: nnavai@mdanderson.org.
Publikováno v:
Urologic oncology [Urol Oncol] 2021 Apr; Vol. 39 (4), pp. 237.e1-237.e5. Date of Electronic Publication: 2020 Dec 08.
Autor:
Nabelsi, Véronique1 (AUTHOR) veronique.nabelsi@uqo.ca, Plouffe, Véronique2 (AUTHOR)
Publikováno v:
BMC Health Services Research. 10/29/2024, Vol. 24 Issue 1, p1-12. 12p.